Therapeutic Drug Monitoring and Drug Quantification

Business development in clinical trials aiming at developing and implementing growth opportunities within CRO’s, the basis for business development is successful Sponsor-CRO partnership and development of strategies to attract sponsors, pharmaceutical companies and nonprofit organizations.

The global market for portable medical equipment products (PMEPS) will grow from $54.2 billion in 2015 to $65.7 billion in 2020 with a compound annual growth rate (CAGR) of 3.9% for the period of 2015-2020.Examination of portable medical electronic products, specifically medical diagnostic equipment and imaging systems, drug delivery devices, interventional medical electronics, first-aid equipment, and body function testers. Analysis of market trends, with data for 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.

The changing requirements in drug development are leading CROs and sponsor companies to form more collaborative and strategic partnerships. "Since 2005, the biopharmaceutical industry has seen a steady increase in strategic outsourcing relationships between pharmaceutical companies and CROs

  • New therapeutic targets in drug design/discovery
  • Evaluation of dose related toxicity and therapeutic inefficacy
  • Individual Drugs TDM
  • TDM Challenges and Advances
  • Thin layer chromatography (TLC), HPLC and GLS
  • Radio immuno assay (RIA) and Enzyme Immuno assay
  • Fluorescence polarization Immunoassay (FPIA)
  • Gender & Pathophysiology

Related Conference of Therapeutic Drug Monitoring and Drug Quantification

Therapeutic Drug Monitoring and Drug Quantification Conference Speakers